Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

What can artificial intelligence teach us about the molecular mechanisms underlying disease?

Cook GJR, Goh V.

Eur J Nucl Med Mol Imaging. 2019 Jun 12. doi: 10.1007/s00259-019-04370-z. [Epub ahead of print]

PMID:
31190176
2.

UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.

Afaq A, Gleeson F, Scarsbrook A, Bradley K, Subesinghe M, Macpherson R, Haroon A, Patel N, Chua S, Wong WL, Vinjamuri S, Warbey VS, Cook GJ, Bomanji J.

Nucl Med Commun. 2019 Jul;40(7):662-674. doi: 10.1097/MNM.0000000000001030.

PMID:
31145206
3.

Loco-regional staging of malignant pleural mesothelioma by integrated 18F-FDG PET/MRI.

Murphy DJ, Mak SM, Mallia A, Jeljeli S, Stirling JJ, Goh V, Bille A, Cook GJR.

Eur J Radiol. 2019 Jun;115:46-52. doi: 10.1016/j.ejrad.2019.04.003. Epub 2019 Apr 5.

PMID:
31084758
4.

MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.

Owczarczyk K, Prezzi D, Cascino M, Kozarski R, Gaya A, Siddique M, Cook GJ, Glynne-Jones R, Goh V.

Radiother Oncol. 2019 May;134:119-126. doi: 10.1016/j.radonc.2019.01.022. Epub 2019 Feb 7.

5.

Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer.

Baiocco S, Sah BR, Mallia A, Kelly-Morland C, Neji R, Stirling JJ, Jeljeli S, Bevilacqua A, Cook GJR, Goh V.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1478-1484. doi: 10.1007/s00259-019-04306-7. Epub 2019 Mar 27.

6.

Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model.

Bashir U, Weeks A, Goda JS, Siddique M, Goh V, Cook GJ.

Nucl Med Commun. 2019 Jun;40(6):611-617. doi: 10.1097/MNM.0000000000000992.

PMID:
30893213
7.

Adaptive statistical iterative reconstruction (ASIR) affects CT radiomics quantification in primary colorectal cancer.

Prezzi D, Owczarczyk K, Bassett P, Siddique M, Breen DJ, Cook GJR, Goh V.

Eur Radiol. 2019 Mar 18. doi: 10.1007/s00330-019-06073-3. [Epub ahead of print]

PMID:
30887205
8.

Early phase I study of a 99mTc labeled anti-PD-L1 single domain antibody in SPECT/CT assessment of programmed death ligand-1 expression in non-small cell lung cancer.

Xing Y, Chand G, Liu C, Cook GJR, O' Doherty J, Zhao L, Wong NCL, Meszaros LK, Ting HH, Zhao J.

J Nucl Med. 2019 Feb 22. pii: jnumed.118.224170. doi: 10.2967/jnumed.118.224170. [Epub ahead of print]

PMID:
30796165
9.

Lateral Unicompartmental Knee Arthroplasty Utilizing a Modified Surgical Technique and Specifically Adapted Fixed-Bearing Implant.

Greco NJ, Cook GJE, Lombardi AV Jr, Adams JB, Berend KR.

Surg Technol Int. 2019 May 15;34:371-378.

PMID:
30574682
10.

Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging.

Azad GK, Taylor BP, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR.

Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830. doi: 10.1007/s00259-018-4223-9. Epub 2018 Dec 1.

11.

Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.

Pencharz D, Dunn J, Connor S, Siddiqui A, Sriskandan N, Thavaraj S, Jeannon JP, Oakley R, Lei M, Guerrero-Urbano T, Cook GJ, Szyszko TA.

Clin Radiol. 2019 Feb;74(2):165.e17-165.e23. doi: 10.1016/j.crad.2018.10.007. Epub 2018 Nov 16.

PMID:
30454841
12.

Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer.

Bashir U, Foot O, Wise O, Siddique MM, Mclean E, Bille A, Goh V, Cook GJ.

Nucl Med Commun. 2018 Dec;39(12):1197-1206. doi: 10.1097/MNM.0000000000000925.

PMID:
30379750
13.

Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUVmax in [18F]fluoride and [18F]FDG PET?

Azad GK, Cousin F, Siddique M, Taylor B, Goh V, Cook GJR.

Mol Imaging Biol. 2018 Sep 24. doi: 10.1007/s11307-018-1262-3. [Epub ahead of print]

PMID:
30250989
14.

Multi-Tracer Guided PET Image Reconstruction.

Ellis S, Mallia A, McGinnity CJ, Cook GJR, Reader AJ.

IEEE Trans Radiat Plasma Med Sci. 2018 Sep;2(5):499-509. doi: 10.1109/TRPMS.2018.2856581. Epub 2018 Jul 23.

15.

Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients.

Arshad MA, Thornton A, Lu H, Tam H, Wallitt K, Rodgers N, Scarsbrook A, McDermott G, Cook GJ, Landau D, Chua S, O'Connor R, Dickson J, Power DA, Barwick TD, Rockall A, Aboagye EO.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):455-466. doi: 10.1007/s00259-018-4139-4. Epub 2018 Sep 1.

16.

Radiomics in esophageal and gastric cancer.

Sah BR, Owczarczyk K, Siddique M, Cook GJR, Goh V.

Abdom Radiol (NY). 2019 Jun;44(6):2048-2058. doi: 10.1007/s00261-018-1724-8. Review.

PMID:
30116873
17.

Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?

Azad GK, Siddique M, Taylor B, Green A, O'Doherty J, Gariani J, Blake GM, Mansi J, Goh V, Cook GJR.

J Nucl Med. 2019 Mar;60(3):322-327. doi: 10.2967/jnumed.118.208710. Epub 2018 Jul 24.

18.

Functional and Hybrid Imaging of Bone Metastases.

Cook GJ, Goh V.

J Bone Miner Res. 2018 Jun;33(6):961-972. doi: 10.1002/jbmr.3444. Epub 2018 May 23.

19.

Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment.

Cook GJR, Azad GK, Taylor BP, Lee E, Morrison MS, Hughes S, Morris S, Rudman S, Chowdhury S, Goh V.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):898-903. doi: 10.1007/s00259-017-3926-7. Epub 2018 Feb 2.

20.

Challenges and Promises of PET Radiomics.

Cook GJR, Azad G, Owczarczyk K, Siddique M, Goh V.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1083-1089. doi: 10.1016/j.ijrobp.2017.12.268. Epub 2018 Jan 31. Review.

21.

Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.

Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Teoh EJ, Bottomley D, Scarsbrook A, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Chau A, Ward P, Miller MP, Stevens DJ, Wilson L, Gleeson FV, Scheidhauer K, Seidl C, Autenrieth M, Bruchertseifer F, Apostolidis C, Kurtz F, Horn T, Pfob C, Schwaiger M, Gschwend J, D'Alessandria C, Morgenstern A, Uprimny C, Kroiss A, Decristoforo C, von Guggenberg E, Nilica B, Horninger W, Virgolini I, Rasul S, Poetsch N, Woehrer A, Preusser M, Mitterhauser M, Wadsak W, Widhalm G, Mischkulnig M, Hacker M, Traub-Weidinger T, Wright CL, Binzel K, Wuthrick EJ, Miller ED, Maniawski P, Zhang J, Knopp MV, Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L, Mairinger S, Filip T, Sauberer M, Flunkert S, Wanek T, Stanek J, Okamura N, Langer O, Kuntner C, Fornito MC, Balzano R, Di Martino V, Cacciaguerra S, Russo G, Seifert D, Kleinova M, Cepa A, Ralis J, Hanc P, Lebeda O, Mosa M, Vandenberghe S, Mikhaylova E, Borys D, Viswanath V, Stockhoff M, Efthimiou N, Caribe P, Van Holen R, Karp JS, Binzel K, Zhang J, Wright CL, Maniawski P, Knopp MV, Haller PM, Farhan C, Piackova E, Jäger B, Knoll P, Kiss A, Podesser BK, Wojta J, Huber K, Mirzaei S, Traxl A, Komposch K, Glitzner E, Wanek T, Mairinger S, Sibilia M, Langer O, Fornito MC, Russello M, Russo G, Balzano R, Sorko S, Gallowitsch HJ, Kohlfuerst S, Matschnig S, Rieser M, Sorschag M, Lind P, Ležaič L, Rep S, Žibert J, Frelih N, Šuštar S, Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Baum RP, Langbein T, Singh A, Shahinfar M, Schuchardt C, Volk GF, Kulkarni HR, Fornito MC, Cacciaguerra S, Balzano R, Di Martino GV, Russo G, Thomson WH, Kudlacek M, Karik M, Farhan C, Rieger H, Pokieser W, Glaser K, Mirzaei S, Petz V, Tugendsam C, Buchinger W, Schmoll-Hauer B, Schenk IP, Rudolph K, Krebs M, Zettinig G, Zoufal V, Wanek T, Krohn M, Mairinger S, Stanek J, Sauberer M, Filip T, Pahnke J, Langer O, Weitzer F, Pernthaler B, Salamon S, Aigner R, Koranda P, Henzlová L, Kamínek M, Váchalová M, Bachleda P, Summer D, Garousi J, Oroujeni M, Mitran B, Andersson KG, Vorobyeva A, Löfblom JN, Orlova A, Tolmachev V, Decristoforo C, Kaeopookum P, Summer D, Orasch T, Lechner B, Petrik M, Novy Z, Rangger C, Haas H, Decristoforo C.

EJNMMI Res. 2018 Jan 23;8(Suppl 1):5. doi: 10.1186/s13550-017-0354-4. No abstract available.

22.

PET/CT and PET/MRI in head and neck malignancy.

Szyszko TA, Cook GJR.

Clin Radiol. 2018 Jan;73(1):60-69. doi: 10.1016/j.crad.2017.09.001. Epub 2017 Oct 10. Review.

PMID:
29029767
23.

Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice.

Yip C, Cook GJR, Owczarczyk K, Goh V.

Chin Clin Oncol. 2017 Sep;6(Suppl 2):S11. doi: 10.21037/cco.2017.06.06. Review.

24.

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of 18F-FDG PET.

Cook GJR, Lovat E, Siddique M, Goh V, Ferner R, Warbey VS.

Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1845-1852. doi: 10.1007/s00259-017-3733-1. Epub 2017 Jun 7.

25.

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

Paschali AN, Gnanasegaran G, Cook GJ.

Indian J Nucl Med. 2017 Apr-Jun;32(2):122-124. doi: 10.4103/0972-3919.202242.

26.

Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features.

Gourtsoyianni S, Doumou G, Prezzi D, Taylor B, Stirling JJ, Taylor NJ, Siddique M, Cook GJR, Glynne-Jones R, Goh V.

Radiology. 2017 Aug;284(2):552-561. doi: 10.1148/radiol.2017161375. Epub 2017 May 5.

27.

Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy.

Yip C, Weeks A, Shaw K, Siddique M, Chang F, Landau DB, Cook GJ, Goh V.

Transl Oncol. 2017 Jun;10(3):459-467. doi: 10.1016/j.tranon.2017.03.006. Epub 2017 Apr 26.

28.

The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1.

Lovat E, Siddique M, Goh V, Ferner RE, Cook GJR, Warbey VS.

EJNMMI Res. 2017 Dec;7(1):35. doi: 10.1186/s13550-017-0282-3. Epub 2017 Apr 20.

29.

18F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients.

O'Doherty J, Jauregui-Osoro M, Brothwood T, Szyszko T, Marsden PK, O'Doherty MJ, Cook GJR, Blower PJ, Lewington V.

J Nucl Med. 2017 Oct;58(10):1666-1671. doi: 10.2967/jnumed.117.192252. Epub 2017 Apr 6.

30.

Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology.

Cook GJ, Azad G, Padhani AR.

Clin Transl Imaging. 2016;4(6):439-447. Epub 2016 Jul 20. Review.

31.

Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study.

Grootendorst MR, Cariati M, Pinder SE, Kothari A, Douek M, Kovacs T, Hamed H, Pawa A, Nimmo F, Owen J, Ramalingam V, Sethi S, Mistry S, Vyas K, Tuch DS, Britten A, Van Hemelrijck M, Cook GJ, Sibley-Allen C, Allen S, Purushotham A.

J Nucl Med. 2017 Jun;58(6):891-898. doi: 10.2967/jnumed.116.181032. Epub 2016 Dec 8.

32.

One Coin, No Need to Flip: Shared PET Targets in Cancer and Coronary Artery Disease.

Paschali AN, Nekolla SG, Evangelou K, Cook GJ, Anagnostopoulos CD.

AJR Am J Roentgenol. 2017 Feb;208(2):434-445. doi: 10.2214/AJR.16.16599. Epub 2016 Nov 29. Review.

PMID:
27897437
33.

Imaging biomarker roadmap for cancer studies.

O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC.

Nat Rev Clin Oncol. 2017 Mar;14(3):169-186. doi: 10.1038/nrclinonc.2016.162. Epub 2016 Oct 11. Review.

34.

Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.

Khan K, Athauda A, Aitken K, Cunningham D, Watkins D, Starling N, Cook GJ, Kalaitzaki E, Chau I, Rao S.

Oncologist. 2016 Dec;21(12):1502-1508. Epub 2016 Oct 14.

35.

CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice.

Cai Q, Jeannet R, Hua WK, Cook GJ, Zhang B, Qi J, Liu H, Li L, Chen CC, Marcucci G, Kuo YH.

Blood. 2016 Sep 15;128(11):1503-15. doi: 10.1182/blood-2016-01-693119. Epub 2016 Jul 21.

36.

PET Imaging of Skeletal Metastases and Its Role in Personalizing Further Management.

Mahajan A, Azad GK, Cook GJ.

PET Clin. 2016 Jul;11(3):305-18. doi: 10.1016/j.cpet.2016.02.003. Epub 2016 Mar 23. Review.

PMID:
27321034
37.

Imaging Heterogeneity in Lung Cancer: Techniques, Applications, and Challenges.

Bashir U, Siddique MM, Mclean E, Goh V, Cook GJ.

AJR Am J Roentgenol. 2016 Sep;207(3):534-43. doi: 10.2214/AJR.15.15864. Epub 2016 Jun 15. Review.

PMID:
27305342
38.

Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare Tumor.

Pelizzo MR, Conti C, Pennelli G, Bellan E, Cook GJ, Wong KK, Colletti PM, Merante Boschin I, Rubello D.

Am J Clin Oncol. 2018 Apr;41(4):416-423. doi: 10.1097/COC.0000000000000295.

PMID:
27163832
39.

Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.

Keramida G, Dunford A, Siddique M, Cook GJ, Peters AM.

Eur J Radiol. 2016 May;85(5):1012-5. doi: 10.1016/j.ejrad.2016.02.026. Epub 2016 Mar 3.

PMID:
27130064
40.

Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.

Yip C, Cook GJ, Wee J, Fong KW, Tan T, Goh V.

Chin Clin Oncol. 2016 Apr;5(2):24. doi: 10.21037/cco.2016.03.16. Review.

41.

A Role for Tumor Volume Assessment in Resectable Esophageal Cancer.

Tullie LG, Sohn HM, Zylstra J, Mattsson F, Griffin N, Sharma N, Porté F, Ramage L, Cook GJ, Gossage JA, Mason RC, Lagergren J, Davies AR.

Ann Surg Oncol. 2016 Sep;23(9):3063-70. doi: 10.1245/s10434-016-5228-x. Epub 2016 Apr 25.

PMID:
27112584
42.

Multi-technique imaging of bone metastases: spotlight on PET-CT.

Azad GK, Cook GJ.

Clin Radiol. 2016 Jul;71(7):620-31. doi: 10.1016/j.crad.2016.01.026. Epub 2016 Mar 17. Review.

PMID:
26997430
43.

The role of new PET tracers for lung cancer.

Szyszko TA, Yip C, Szlosarek P, Goh V, Cook GJ.

Lung Cancer. 2016 Apr;94:7-14. doi: 10.1016/j.lungcan.2016.01.010. Epub 2016 Jan 21. Review.

PMID:
26973200
44.

Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition.

Kuo YH, Qi J, Cook GJ.

Exp Hematol. 2016 May;44(5):315-21. doi: 10.1016/j.exphem.2016.02.007. Epub 2016 Feb 26. Review.

45.

Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation.

Maccauro M, Lorenzoni A, Crippa F, Manca G, Chondrogiannis S, Giammarile F, Colletti PM, Cook GJ, Rubello D.

Clin Nucl Med. 2016 Jun;41(6):e288-93. doi: 10.1097/RLU.0000000000001184. Review.

PMID:
26914577
46.

Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.

Manca G, Tardelli E, Rubello D, Gennaro M, Marzola MC, Cook GJ, Volterrani D.

Nucl Med Commun. 2016 Jun;37(6):570-6. doi: 10.1097/MNM.0000000000000489. Review.

PMID:
26886421
47.

PET/MRI in Oncological Imaging: State of the Art.

Bashir U, Mallia A, Stirling J, Joemon J, MacKewn J, Charles-Edwards G, Goh V, Cook GJ.

Diagnostics (Basel). 2015 Jul 21;5(3):333-57. doi: 10.3390/diagnostics5030333. Review.

48.

Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.

Cook GJ, Azad GK, Goh V.

J Nucl Med. 2016 Feb;57 Suppl 1:27S-33S. doi: 10.2967/jnumed.115.157867. Review.

49.

Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.

Wong KK, Miller BS, Viglianti BL, Dwamena BA, Gauger PG, Cook GJ, Colletti PM, Rubello D, Gross MD.

Clin Nucl Med. 2016 Aug;41(8):e368-82. doi: 10.1097/RLU.0000000000001112. Review.

PMID:
26825212
50.

Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases.

Limouris GS, Poulantzas V, Trompoukis N, Karfis I, Chondrogiannis S, Triantafyllou N, Gennimata V, Moulopoulou LE, Patsouris E, Nikou G, Michalaki V, Fragulidis G, Paphiti M, McCready RV, Colletti PM, Cook GJ, Rubello D.

Clin Nucl Med. 2016 Mar;41(3):194-200. doi: 10.1097/RLU.0000000000001096.

PMID:
26673241

Supplemental Content

Support Center